Tissue-engineered blood vessels as promising tools for testing drug toxicity

Expert Opinion on Drug Metabolism and Toxicology

Volumn 11, Issue 7, 2015, Pages 1021-1024

  Truskey, George A ^a   Fernandez, Cristina E ^a  

^a Duke University   (United States)

Author keywords

Drug induced vascular injury; Drug toxicity; Endothelial dysfunction; Tissue engineered blood vessels; Vasoactivity

Indexed keywords

BIOLOGICAL MARKER;

BLOOD VESSEL; BLOOD VESSEL INJURY; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CANCER SURVIVOR; DRUG INDUSTRY; DRUG SCREENING; HUMAN; NONHUMAN; REVIEW; TISSUE ENGINEERING; TOXICITY TESTING; ANIMAL; BLOOD VESSEL PROSTHESIS; CHEMICALLY INDUCED; DRUG DESIGN; DRUG EFFECTS; HIGH THROUGHPUT SCREENING; METABOLISM; PRECLINICAL STUDY; PROCEDURES; SPECIES DIFFERENCE; VASCULAR DISEASES;

ANIMALIA; RODENTIA;

ANIMALS; BIOMARKERS; BLOOD VESSEL PROSTHESIS; BLOOD VESSELS; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; SPECIES SPECIFICITY; TISSUE ENGINEERING; TOXICITY TESTS; VASCULAR DISEASES;

EID: 84931028864     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2015.1047342     Document Type: Review

References (16)

1. Tousoulis D, Kampoli AM, Tentolouris C, et al. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10:4-18
2. Iglarz M, Clozel M. At the heart of tissue: endothelin system and end organ damage. Clin Sci 2010;119:453-63
3. Lind L, Berglund L, Larsson A, Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011;123:1545-51
4. Zhang J, Defelice AF, Hanig JP, Colatsky T. Biomarkers of endothelial cell activation serve as potential surrogate markers for drug-induced vascular injury. Toxicol Pathol 2010;38:856-71
5. Tobin GA, Zhang J, Goodwin D, et al. The Role of eNOS Phosphorylation in Causing Drug-induced Vascular Injury. Toxicol Pathol 2014;42(4):709-24
6. Jenei Z, Bárdi E, Magyar MT, et al. Anthracycline Causes Impaired Vascular Endothelial Function and Aortic Stiffness in Long Term Survivors of Childhood Cancer. Pathol Oncol Res 2013;19:375-83
7. Brouwer CA, Postma A, Hooimeijer HL, et al. Endothelial Damage in Long-Term Survivors of Childhood Cancer. J Clin Oncol 2013;31(31):3906-13
8. Fernandez CE, Achneck HE, Reichert WM, Truskey GA. Biological and engineering design considerations for vascular tissue engineered blood vessels (TEBVs). Curr Opin Chem Eng 2014;3:83-90
9. Lippmann ES, Al-Ahmad A, Azarin SM, et al. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci Rep 2014;4:4160
10. Johansson S. Cardiovascular lesions in Sprague-Dawley rats induced by longterm treatment with caffeine. Acta pathologica et microbiologica Scandinavica Section A. Pathology 1981;89(3):185-91
11. Vilahur G, Cubedo J, Padro T, et al. Roflumilast-induced local vascular injury is associated with a coordinated proteome and microparticle change in the systemic circulation in pigs. Toxicol Pathol 2014. Available from: http://tpx.sagepub.com/content/early/2014/10/10/0192623314551971; doi: 10.1177/0192623314551971
12. Soultati A, Mountzios G, Avgerinou C, et al. Endothelial vascular toxicity from chemotherapeutic agents: Preclinical evidence and clinical implications. Cancer Treat Rev 2012;38:473-83
13. Enerson BE, Lin A, Lu B, et al. Acute drug-induced vascular injury in beagle dogs: pathology and correlating genomic expression. Toxicol Pathol 2006;34(1):27-32
14. Brott DA, Richardson RJ, Louden CS. Evidence for the nitric oxide pathway as a potential mode of action in fenoldopam-induced vascular injury. Toxicol Pathol 2012;40(6):874-86
15. Mesfin GM, Piper RC, DuCharme DW, et al. Pathogenesis of cardiovascular alterations in dogs treated with minoxidil. Toxicol Pathol 1989;17(1 Pt 2):164-81
16. Albassam MA, Metz AL, Potoczak RE, et al. Studies on coronary arteriopathy in dogs following administration of CI-1020, an endothelin A receptor antagonist. Toxicol Pathol 2001;29:277-84